Banco De Sabadell, S.A Astrazeneca PLC Transaction History

Banco De Sabadell, S.A

$151 Million
Q3 2025

A detailed history of Banco De Sabadell, S.A transactions in Astrazeneca PLC stock. As of the latest transaction made, Banco De Sabadell, S.A holds 5,534 shares of AZN stock, worth $494,739. This represents 0.28% of its overall portfolio holdings.

Number of Shares

5,534

Previous 6,017 8.03%

Holding current value

$494,739

Previous $418,000 0.48%

% of portfolio

0.28%

Previous 0.29%

26 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2025 Nov 13, 2025	SELL	$68.72 - $82.11 $33,191 - $39,659	-483 Reduced 8.03%	5,534 $420,000
Q2 2025 Aug 13, 2025	SELL	$64.87 - $75.0 $186,306 - $215,400	-2,872 Reduced 32.31%	6,017 $418,000
Q1 2025 May 14, 2025	BUY	$65.37 - $77.96 $6,275 - $7,484	96 Added 1.09%	8,889 $652,000
Q4 2024 Feb 11, 2025	BUY	$63.2 - $79.58 $76,408 - $96,212	1,209 Added 15.94%	8,793 $575,000
Q3 2024 Nov 14, 2024	BUY	$76.67 - $87.62 $42,935 - $49,067	560 Added 7.97%	7,584 $593,000

Q2 2024 Aug 13, 2024	BUY	$66.81 - $80.83 $14,631 - $17,701	219 Added 3.22%	7,024 $545,000
Q1 2024 May 13, 2024	SELL	$61.03 - $69.57 $1,647 - $1,878	-27 Reduced 0.4%	6,805 $458,000
Q4 2023 Feb 09, 2024	SELL	$61.89 - $69.28 $1,114 - $1,247	-18 Reduced 0.26%	6,832 $455,000
Q3 2023 Nov 13, 2023	BUY	$64.85 - $71.7 $92,411 - $102,172	1,425 Added 26.27%	6,850 $460,000
Q2 2023 Aug 14, 2023	SELL	$69.91 - $75.81 $1,468 - $1,592	-21 Reduced 0.39%	5,425 $386,000
Q1 2023 May 12, 2023	SELL	$63.15 - $71.6 $14,335 - $16,253	-227 Reduced 4.0%	5,446 $381,000
Q4 2022 Feb 14, 2023	BUY	$54.21 - $70.44 $6,071 - $7,889	112 Added 2.01%	5,673 $384,000
Q3 2022 Nov 10, 2022	SELL	$53.02 - $135.75 $38,121 - $97,604	-719 Reduced 11.45%	5,561 $304,000
Q2 2022 Aug 11, 2022	SELL	$59.26 - $71.14 $9,896 - $11,880	-167 Reduced 2.59%	6,280 $412,000
Q1 2022 May 12, 2022	BUY	$55.72 - $67.12 $25,519 - $30,740	458 Added 7.65%	6,447 $425,000
Q4 2021 Feb 14, 2022	BUY	$54.02 - $63.83 $29,819 - $35,234	552 Added 10.15%	5,989 $351,000
Q3 2021 Nov 04, 2021	SELL	$55.56 - $60.79 $17,612 - $19,270	-317 Reduced 5.51%	5,437 $328,000
Q2 2021 Aug 13, 2021	BUY	$48.42 - $60.18 $18,399 - $22,868	380 Added 7.07%	5,754 $344,000
Q1 2021 May 14, 2021	SELL	$47.16 - $54.44 $5,281 - $6,097	-112 Reduced 2.04%	5,374 $266,000
Q4 2020 Feb 12, 2021	BUY	$48.52 - $58.02 $17,806 - $21,293	367 Added 7.17%	5,486 $274,000
Q3 2020 Nov 13, 2020	BUY	$53.07 - $61.1 $8,544 - $9,837	161 Added 3.25%	5,119 $279,000
Q2 2020 Aug 07, 2020	SELL	$43.1 - $55.31 $25,946 - $33,296	-602 Reduced 10.83%	4,958 $263,000
Q1 2020 May 14, 2020	BUY	$37.79 - $51.33 $1,587 - $2,155	42 Added 0.76%	5,560 $250,000
Q4 2019 Feb 14, 2020	SELL	$42.46 - $50.46 $7,855 - $9,335	-185 Reduced 3.24%	5,518 $276,000
Q3 2019 Nov 15, 2019	SELL	$40.12 - $45.47 $5,135 - $5,820	-128 Reduced 2.2%	5,703 $256,000
Q2 2019 Aug 13, 2019	BUY	$37.28 - $41.68 $217,379 - $243,036	5,831 New	5,831 $242,000

Others Institutions Holding AZN

# of Institutions

1,498

Shares Held

500M

Call Options Held

5.59M

Put Options Held

3.18M

View Full List

About ASTRAZENECA PLC

Ticker AZN
Exchange OTC
Sector Healthcare
Industry Drug Manufacturers—General
Shares Outstandng 3,099,020,032
Market Cap $277B
Description
AstraZeneca PLC, a biopharmaceutical company, focuses on the discovery, development, manufacturing, and commercialization of prescription medicines. Its marketed products include Calquence, Enhertu, Faslodex, Imfinzi, Iressa, Koselugo, Lumoxiti, Lynparza, Orpathys, Tagrisso, and Zoladex for oncology; Brilinta/Brilique, Bydureon/Byetta, BCise, By...

More about AZN

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Banco De Sabadell, S.A, based on Form 13F filings with the SEC.

News

Stay updated on Banco De Sabadell, S.A with notifications on news.

Account

Banco De Sabadell, S.A Astrazeneca PLC Transaction History